Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy from Other Cardiomyopathies with Left Ventricular Hypertrophy

Akita, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., & Shimada, Y. J. (2024). Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy from Other Cardiomyopathies with Left Ventricular Hypertrophy. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.124.012434
Authors:
Keitaro Akita
Mathew S Maurer
Albree Tower-Rader
Michael A Fifer
Yuichi J Shimada
Affiliated Authors:
Keitaro Akita
Mathew S Maurer
Yuichi J Shimada
Columbia Affiliation:
Author Keywords:
aortic valve stenosis
biomarkers
cardiomyopathies
cardiomyopathy, hypertrophic
hypertrophy, left ventricular
elink
Publication Type:
Article
Unique ID:
10.1161/circheartfailure.124.012434
PMID:
39523983
DOI:
10.1161/circheartfailure.124.012434
Journal:
Circulation: Heart Failure
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: